Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...

IntroductionProgrammed cell death protein 1 (PD-1) and its ligand, PD-L1, are crucial immune checkpoints that regulate the ...

Each cell in your body relies on precise communication with other cells to function properly. At the center of this process ...

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...

Writing in Cell, Yang et al. identify the adhesion G-protein coupled receptor (aGPCR ... target GPR133 but not the androgen binding site in the AR. Applying filters, clustering analysis ...

Researchers from Washington University School of Medicine and Stanford University have developed a compound that simulates a ...

A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the SARS-CoV-2 virus that causes COVID-19, raising the possibility that it could someday spread ...

An international group of researchers has identified an important mechanism that enables stem cells to evade immune rejection ...

The scientists said that like SARS-CoV-2, the bat virus HKU5-CoV-2 contains a feature known as the furin cleavage site that helps it to enter cells via the ACE2 receptor protein on cell surfaces.

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...

Student scientists have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ...